Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein L45 pseudogene 2 (MRPL45P2) is a human pseudogene, meaning it is a non-functional genomic copy of the functional MRPL45 gene. Pseudogenes like MRPL45P2 typically arise via duplication or mutation events and do not encode active proteins. MRPL45P2 does not have any confirmed biological function, is not expressed as a functional protein, and is not considered a drug target. Its relevance in biomedical research is as a genomic relic without a known role in health or disease. Pseudogenes such as MRPL45P2 are sometimes studied for genomic evolution or potential regulatory impacts at the RNA level, but there is no direct evidence of such a role for MRPL45P2[2][3][5][6]. Key points: - MRPL45P2 is a pseudogene, not a functional gene or protein[2][3]. - It is not considered a therapeutic target or a disease biomarker. - There are no known drug interactions or mechanisms of action. - This target is likely incorrect if sought for pharmacological or therapeutic relevance.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L45 pseudogene 2 (MRPL45P2).